Lack of effect of aspirin in primary CV prevention in type 2 diabetic patients with nephropathy: res...
Lack of effect of aspirin in primary CV prevention in type 2 diabetic patients with nephropathy: results from 8 years follow-up of NID-2 study
About this item
Full title
Author / Creator
Publisher
Milan: Springer Milan
Journal title
Language
English
Formats
Publication information
Publisher
Milan: Springer Milan
Subjects
More information
Scope and Contents
Contents
The risk-to-benefit ratio for the use of low dose of aspirin in primary cardiovascular (CV) prevention in patients with diabetes mellitus remains to be clarified. We assessed the effect of aspirin on risk of CV events in type 2 diabetic patients with nephropathy, in order to verify the usefulness of Guidelines in clinical practice. We carried out a...
Alternative Titles
Full title
Lack of effect of aspirin in primary CV prevention in type 2 diabetic patients with nephropathy: results from 8 years follow-up of NID-2 study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1785234512
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1785234512
Other Identifiers
ISSN
0940-5429
E-ISSN
1432-5233
DOI
10.1007/s00592-014-0623-x
